Searched for
AUROBINDO PHARMA Q3 RESULTS
Ashok Leyland just had a record June quarter. So why did the margin fall a full point?Ashok Leyland's June-quarter has an unusual contradiction. The company sold 48,763 commercial vehicles, its highest-ever first-quarter volu...- Retail leasing moderated by 7.3% quarter-on-quarterIndia’s retail real estate sector showed active occupier demand with gross leasing volume reaching 2.22 million square feet. Main streets r...
- RIL Q2 Results: Nuvama sees 17% EBITDA growth, led by O2C biz. Here’s what to expectReliance Industries is expected to report 17% year-on-year growth in Q2FY27 EBITDA to Rs 53,700 crore, led by stronger refining margins and...
- Stocks in news: Infosys, HDFC Bank, Jio Financial, IRFC, NCC and Blue DartIndian equity benchmarks experienced a decline over two sessions due to profit booking and rising oil prices. The Nifty 50 index closed dow...
- Q2 earnings: Can India Inc repeat Q1, or will Q3 erase the base-effect tailwind?India Inc is likely to see a dip in earnings performance for Q2 in comparison to Q1, with analysts forecasting a growth slowdown of roughly...
- TCS, Wipro, other IT stocks rebound up to 6%, snapping 8-day losing streak. Why is Jefferies cautious?IT stocks rebounded on Wednesday, with TCS, Wipro and Coforge snapping an eight-session losing streak. The Nifty IT index rose nearly 3%, a...
- Morgan Stanley raises Lenskart target price to Rs 718; bull case implies 41% upside. Here’s whyLenskart Solutions reported a 182.3% YoY rise in Q1 FY27 net profit to Rs 228 crore, while revenue grew 33.6% to Rs 2,214 crore. EBITDA mar...
- SC seeks 16% MRP cap on medicines, flags huge cancer drug markupsThe Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...
- Ahead of Market: 10 things that will decide stock market action on WednesdayNifty’s indicative price plunged 2% in two seconds during the closing auction session on monthly expiry, before recovering sharply. Analyst...
- Two Trades for Today: 2 mid-cap pharma stocks, one for a rise of 6.2%, and the other for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- Honasa Consumer shares fall 5% after Rs 643 crore block deal; Peak XV, Sequoia likely sellersHonasa Consumer shares declined up to 5% after 1.4 crore shares worth Rs 643 crore changed hands in a block deal. The transaction comes aft...
- Auto stocks: Festive demand gets a low-base boost; can earnings justify valuations?The Indian automobile market is witnessing robust retail sales as the festive season draws near. A significant year-on-year uptick of 81.8%...
- Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsIndian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...
- Home sales increase by 3% annually during July-SeptemberHome sales in the top seven cities have shown signs of recovery during the third quarter of 2026. Total sales increased by 3% compared to t...
- Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...
- Suzlon Energy shares fall 2% to near six-month low, down 15% in one monthSuzlon Energy shares slipped over 2% to a near six-month low, approaching their 52-week low amid higher trading volumes and broader market ...
- Audi India starts local assembly of Audi Q3 in Chhatrapati SambhajinagarAudi has commenced local assembly of the Q3 model at the Skoda Auto Volkswagen plant in Chhatrapati Sambhajinagar. The new model is expecte...
- Meesho shares rally 12% after UBS hikes target price by 24%. What’s keeping analysts bullish?UBS has raised its Meesho estimates across NMV, contribution profit and EBITDA, citing stronger seller and buyer growth and improving unit ...
- JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...
Load More
